Shares of Inovio Pharmaceuticals Inc. INO shed 1.18% to $6.69 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 2 ...

Inovio Pharmaceuticals (INO) shares rallied 19% in the last trading session to close at $11.04. This move can be attributable to notable volume with a higher number of shares being traded than in ...

The post INO Stock Earnings: Inovio Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 appeared first on InvestorPlace.

Analyst Stephens covers INOVIO Pharmaceuticals highlighting its diverse clinical pipeline and FDA's consideration of INO-3107 Phase 1/2 trials for Accelerated Approval. Potential as the first non ...

Stock Advisor returns as of August 6 ... That includes advancing our lead INO-3107 development program, advancing other promising candidates in our pipeline, and finally, strengthening our ...

Inovio Pharmaceuticals (INO) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.

As of 13 September at 10:16 GMT-4. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

The stock's fall snapped a six-day winning streak.